Form 4: HCA Healthcare Executive Erol R. Akdamar Reports Stock Transactions
SEC Form 4 Filing
HCA Healthcare's Group President, Erol R. Akdamar, reported multiple transactions involving company stock, including the acquisition of shares through stock appreciation rights and subsequent sales.
Summary
- Erol R. Akdamar, a Group President at HCA Healthcare, filed a Form 4 detailing changes in his beneficial ownership of company stock.
- On November 12, 2024, Akdamar acquired 20,000 shares of common stock through the exercise of stock appreciation rights at a price of $68.96 per share.
- Also on November 12, 2024, 10,257 shares were disposed of to cover tax obligations at a price of $350.53 per share.
- On November 14, 2024, Akdamar sold 2,900 shares at a price of $353 per share.
- Following these transactions, Akdamar directly owns 6,843 shares of common stock.
- Akdamar also indirectly owns 60,497 shares through a family trust and 60,000 shares through an LLC.
Sentiment
Score: 5
Explanation: The document is a routine disclosure of stock transactions by an executive, which is neither positive nor negative in itself. It is a neutral event.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the trading activities of insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
- The transactions are typical for executives who receive stock-based compensation and may sell shares to cover taxes or for personal financial planning.
- The prices at which the shares were sold are consistent with the market price of HCA stock at the time of the transactions.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are routine and do not indicate any significant change in the company's fundamentals.
- The transactions are part of the executive's compensation and personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 2022-12-07 | Date of Power of Attorney execution. |
| 2024-11-12 | Date of stock acquisition and tax obligation sale. |
| 2024-11-14 | Date of additional stock sale. |
Keywords
HCA Healthcare, stock transactions, Form 4, insider trading, stock appreciation rights, executive compensation, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.